Literature DB >> 24121204

Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[(11)C]O-methylreboxetine.

Chiang-shan R Li1, Marc N Potenza2, Dianne E Lee3, Beata Planeta3, Jean-Dominique Gallezot3, David Labaree3, Shannan Henry4, Nabeel Nabulsi3, Rajita Sinha5, Yu-Shin Ding6, Richard E Carson7, Alexander Neumeister8.   

Abstract

OBJECTIVES: Noradrenergic dysfunction is implicated in obesity. The norepinephrine transporter (NET) regulates the synaptic availability of norepinephrine. However, NET availability has not been previously characterized in vivo in obese people using Positron Emission Tomography (PET) imaging. Here we report findings evaluating NET availability in individuals with obesity and matched lean (i.e., normal weight) comparison subjects.
METHODS: Seventeen obese but otherwise healthy individuals with a mean±SD body mass index (BMI) of 34.7±2.6 and 17 lean individuals with a mean±SD BMI of 23.1±1.4 were studied using a high-resolution research tomograph (HRRT) and (S,S)-[(11)C]O-methylreboxetine ([(11)C]-MRB), a radioligand selective for the NET. The regional brain NET binding potential (BPND) was estimated by the multilinear reference tissue model 2 (MRTM2) with the occipital cortex as a reference region. BPND for regions of interest were obtained with the Automated Anatomic Labeling (AAL) template registered to individual's structural MR scans.
RESULTS: Obese individuals had lower NET BPND values in the thalamus (p<0.038, 27% reduction) including within the pulvinar (p<0.083, 30% reduction), but not in the hypothalamus, locus coeruleus or the raphe nuclei, compared to lean individuals. When age was included as a covariate, the difference in NET BPND values remained significant in the thalamus (p<0.025) and pulvinar (p<0.042).
CONCLUSIONS: These results indicate that NET availability is decreased in the thalamus, including the pulvinar, in obese individuals. These findings further support data indicating noradrenergic dysfunction in obesity and suggest impaired NE clearance in obesity.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BMI; Human; Norepinephrine; Obesity; PET; [(11)C]-MRB

Mesh:

Substances:

Year:  2013        PMID: 24121204      PMCID: PMC3947246          DOI: 10.1016/j.neuroimage.2013.10.004

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  33 in total

Review 1.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

2.  Reduced paraventricular nucleus norepinephrine responsiveness in obesity-prone rats.

Authors:  B E Levin
Journal:  Am J Physiol       Date:  1996-02

3.  The pulvinar regulates information transmission between cortical areas based on attention demands.

Authors:  Yuri B Saalmann; Mark A Pinsk; Liang Wang; Xin Li; Sabine Kastner
Journal:  Science       Date:  2012-08-10       Impact factor: 47.728

4.  Brain dopamine and obesity.

Authors:  G J Wang; N D Volkow; J Logan; N R Pappas; C T Wong; W Zhu; N Netusil; J S Fowler
Journal:  Lancet       Date:  2001-02-03       Impact factor: 79.321

Review 5.  Reward mechanisms in obesity: new insights and future directions.

Authors:  Paul J Kenny
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

6.  Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo.

Authors:  Jonas Hannestad; Jean-Dominique Gallezot; Beata Planeta-Wilson; Shu-Fei Lin; Wendol A Williams; Christopher H van Dyck; Robert T Malison; Richard E Carson; Yu-Shin Ding
Journal:  Biol Psychiatry       Date:  2010-08-05       Impact factor: 13.382

7.  Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010.

Authors:  Cynthia L Ogden; Margaret D Carroll; Brian K Kit; Katherine M Flegal
Journal:  JAMA       Date:  2012-01-17       Impact factor: 56.272

8.  Sleep restriction leads to increased activation of brain regions sensitive to food stimuli.

Authors:  Marie-Pierre St-Onge; Andrew McReynolds; Zalak B Trivedi; Amy L Roberts; Melissa Sy; Joy Hirsch
Journal:  Am J Clin Nutr       Date:  2012-02-22       Impact factor: 7.045

9.  Gender differences in the association between body mass index and psychopathology.

Authors:  Rani A Desai; Melinda Manley; Mayur M Desai; Marc N Potenza
Journal:  CNS Spectr       Date:  2009-07       Impact factor: 3.790

10.  Reduction in neural activation to high-calorie food cues in obese endometrial cancer survivors after a behavioral lifestyle intervention: a pilot study.

Authors:  Nora L Nock; Anastasia Dimitropolous; Jean Tkach; Heidi Frasure; Vivan von Gruenigen
Journal:  BMC Neurosci       Date:  2012-06-25       Impact factor: 3.288

View more
  19 in total

1.  The central nervous norepinephrine network links a diminished sense of emotional well-being to an increased body weight.

Authors:  J Melasch; M Rullmann; A Hilbert; J Luthardt; G A Becker; M Patt; A Villringer; K Arelin; P M Meyer; D Lobsien; Y-S Ding; K Müller; O Sabri; S Hesse; B Pleger
Journal:  Int J Obes (Lond)       Date:  2015-10-20       Impact factor: 5.095

2.  Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults.

Authors:  Franziska J Vettermann; Michael Rullmann; Georg A Becker; Julia Luthardt; Franziska Zientek; Marianne Patt; Philipp M Meyer; Anke McLeod; Matthias Brendel; Matthias Blüher; Michael Stumvoll; Anja Hilbert; Yu-Shin Ding; Osama Sabri; Swen Hesse
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-07       Impact factor: 9.236

3.  Central noradrenaline transporter availability in highly obese, non-depressed individuals.

Authors:  Swen Hesse; Georg-Alexander Becker; Michael Rullmann; Anke Bresch; Julia Luthardt; Mohammed K Hankir; Franziska Zientek; Georg Reißig; Marianne Patt; Katrin Arelin; Donald Lobsien; Ulrich Müller; S Baldofski; Philipp M Meyer; Matthias Blüher; Mathias Fasshauer; Wiebke K Fenske; Michael Stumvoll; Anja Hilbert; Yu-Shin Ding; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01-09       Impact factor: 9.236

4.  Compartmental modeling of [(11)C]MENET binding to the norepinephrine transporter in the healthy human brain.

Authors:  Vikram Adhikarla; Fanxing Zeng; John R Votaw; Mark M Goodman; Jonathon A Nye
Journal:  Nucl Med Biol       Date:  2016-02-28       Impact factor: 2.408

Review 5.  Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans.

Authors:  M A van Gestel; E Kostrzewa; R A H Adan; S K Janhunen
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

Review 6.  Central nervous system regulation of eating: Insights from human brain imaging.

Authors:  Olivia M Farr; Chiang-Shan R Li; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-02-06       Impact factor: 8.694

7.  Imaging human brown adipose tissue under room temperature conditions with (11)C-MRB, a selective norepinephrine transporter PET ligand.

Authors:  Janice J Hwang; Catherine W Yeckel; Jean-Dominique Gallezot; Renata Belfort-De Aguiar; Devrim Ersahin; Hong Gao; Michael Kapinos; Nabeel Nabulsi; Yiyun Huang; David Cheng; Richard E Carson; Robert Sherwin; Yu-Shin Ding
Journal:  Metabolism       Date:  2015-03-05       Impact factor: 8.694

8.  Elevated Body Mass Index is Associated with Increased Integration and Reduced Cohesion of Sensory-Driven and Internally Guided Resting-State Functional Brain Networks.

Authors:  Gaelle E Doucet; Natalie Rasgon; Bruce S McEwen; Nadia Micali; Sophia Frangou
Journal:  Cereb Cortex       Date:  2018-03-01       Impact factor: 5.357

9.  Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study.

Authors:  Swen Hesse; Michael Rullmann; Julia Luthardt; Karsten Winter; Mohammed K Hankir; Georg-Alexander Becker; Franziska Zientek; Georg Reissig; Ralf Regenthal; Mandy Drabe; Christian Schinke; Anke Bresch; Katrin Arelin; Donald Lobsien; Marianne Patt; Philipp M Meyer; Mathias Fasshauer; Wiebke K Fenske; Matthias Blüher; Michael Stumvoll; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-18       Impact factor: 9.236

10.  Mild Depressive Symptoms Among Americans in Relation to Physical Activity, Current Overweight/Obesity, and Self-Reported History of Overweight/Obesity.

Authors:  Scott J Dankel; Jeremy P Loenneke; Paul D Loprinzi
Journal:  Int J Behav Med       Date:  2016-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.